Vijaya Diagnostic, Ami Organics to launch IPOs this week
NEW DELHI: The IPO rush will continue in September with two more companies Vijaya Diagnostic Centre and Ami Organics launching their initial share-sales on Wednesday to raise a total of ₹2,465 crore.
This comes after eight companies including Devyani International, Nuvoco Vistas Corporation and CarTrade Tech floated their initial share-sales last month to mobilise ₹18,243 crore.
So far in the current fiscal, a total of 20 companies have mopped up more than ₹45,000 crore through IPOs. This is much higher than ₹31,277 crore raised by 30 firms in the entire 2020-21.
Going forward, market analysts expect the IPO environment to remain buzzing during the entire financial year 2021-22.
The initial public offer (IPO) of healthcare chain Vijaya Diagnostic Centre and specilalty chemicals maker Ami Organics will open for subscription on September 1 and conclude on September 3.
Vijaya Diagnostic’s IPO is entirely an offer for sale of 35,688,064 equity shares by the promoter, S Surendranath Reddy, and investors Karakoram Ltd and Kedaara Capital Alternative Investment FundKedaara Capital AIF I.
As a part of the offer for sale, Reddy will sell 50.98 lakh equity shares,
Karakoram will offload 2.95 crore equity shares and Kedaara Capital will divest 11.02 lakh shares.
The initial share-sale will see stake dilution of 35% by the promoter and existing shareholders.
The company has fixed a price band of ₹522-531 a share for its IPO. At the upper end of the price band, the initial share-sale is expected to fetch ₹1,895 crore.
The IPO of Ami Organics comprises fresh issue of equity shares worth ₹200 crore and an offer for sale of up to 6,059,600 equity shares by existing shareholders.
The company has reduced its fresh issue size to ₹200 crore from ₹300 crore after raising ₹100 crore in a pre-IPO placement.
The price band has been set at Rs 603-610 a share for the public issue. At the upper end of the price band, the initial share-sale is expected to fetch ₹569.63 crore. Proceeds from the fresh issue will be used towards repayment of certain debt and funding working capital requirements.
Ami Organics is one of the leading R&D driven manufacturers of specialty chemicals with varied end usage, focussed towards the development and manufacturing of pharma intermediates for regulated and generic APIs (active pharmaceutical ingredients) and NCE (new chemical entity) and key starting material for agrochemical and fine chemicals.
The equity shares of both companies will be listed on BSE and NSE.